Lutetium-177 vipivotide tetraxetan for treating PSMA-positive hormone-relapsed metastatic prostate cancer after an anti-androgen but not a taxane [ID6743]

• Awaiting development
• Reference number: GID-TA11969
• Expected publication date: TBC